3-氯-5-甲基哒嗪，CAS 登记号 89283-31-8，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 3-氯-5-甲基哒嗪 的 CAS 号：89283-31-8，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
3-Chloro-5-methylpyridazine · CAS 89283-31-8 · C5H5ClN2.
| CAS Registry Number | 89283-31-8 |
|---|---|
| PubChem CID | 21766140 |
| Molecular formula | C5H5ClN2 |
| IUPAC name | 3-chloro-5-methylpyridazine |
| Molecular Weight | 128.56 |
|---|---|
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 128.0141259 |
| Monoisotopic Mass | 128.0141259 |
| Topological Polar Surface Area | 25.8 |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Reported hazard statements | H302, H312, H332 (25%), H315 (50%), H319 (50%), H335 (50%), H351 (25%) |
|---|
H302+H312+H332 (25%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
H302 (25%): Harmful if swallowed [Warning Acute toxicity, oral]
3-Chloro-5-methylpyridazine; 89283-31-8; DTXSID90617782; RefChem:278423; DTXCID20568536; 696-078-4; MFCD09743645; Pyridazine, 3-chloro-5-methyl-; 3-Chloro-5-methylpyridazine, 3.3% w/v in methylene dichloride; SCHEMBL790511; SCHEMBL802304; SCHEMBL25398608; SCHEMBL30356599; 3-chloro-5-methylpyridazine97%; 3-chloro-5-methyl-1,2-diazine; GXBWRBSCBONTKK-UHFFFAOYSA-N
CAS 89283-31-8; molecular formula C5H5ClN2; molecular weight — g/mol.
3-Chloro-5-methylpyridazine, 89283-31-8, DTXSID90617782, RefChem:278423, DTXCID20568536, 696-078-4.
Hazard statements reported: H302, H312, H332, H315, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.